Clinical TrialsSearch results
Number of results: 660
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Randomized controlled trial to evaluate para-aortic lymphadenectomy for gastric cancer (JCOG9501)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-06
Other
- A randomised controlled trial to evaluate the effectiveness of perioperative immunonutrition and synbiotics in living-donor liver transplant recipients on reduction of postoperative infectious complication.
- Patients scheduled for living-donor liver transplantation.
- Department of Infection Control and Prevention, Kyoto University Hospital
- 2005-09-07
Other
- Gene evaluation for antihypertensive drug effects study
- essential hypertension
- National Cardiovascular Center
- 2005-09-07
Other
- Randomized controlled trial to evaluate surgical approaches to gastric cancer invading the esophagus (JCOG9502)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-07
Other
- Randomized phase III study of 5-FU continuous infusion (5FUci) versus MTX+5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU)
- gastric cancer with peritoneal metastasis
- Japan Clinical Oncology Group(JCOG)
- 2005-09-07
Other
- Investigation of the Optimal Treatment Strategy for Atrial Fibrillation in Japan -The J-RHYTHM (Japanese Rhythm Management Trial for Atrial Fibrillation) Study-
- Atrial Fibrillation
- The J-RHYTHM Investigators
- 2005-09-08
Other
- Japanese Extracranial-Intracranial Arterial Bypass Trial
- Symptomatic internal carotid artery or middle cerebral artery occlusion or stenosis
- JET Study Group
- 2005-09-08
Other
- MCA Embolism Local Fibrinolytic Intervention Trial
- Middle cerebral artery embolism
- MELT Study Group
- 2005-09-08
Other
- Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)
- gastric neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2005-09-08
Other
- A phase I/II study of concurrent chemoradiotherapy with irinotecan for advanced or recurrent uterine cancer
- uterine cancer (squamous cell carcinoma, adeno- and/or adenosquamous cell carcinoma, endometrial carcinoma, carcinosarcoma)
- National Hospital Organization Kobe Medical Center
- 2005-09-09